News

uMotif nominated for OBN award
uMotif secures £2.4 million funding – led by Albion Capital
uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board
uMotif attending SCDM 2018 Annual Conference in Seattle
Guardian Article: The app that could save lives by speeding up drug trials
Our employee interview series continues with a technology focus
Knect 365 article: Enabling Bring Your Own Device Clinical Data Collection
uMotif and OMRON Healthcare join forces to deliver patient-centred clinical research of the future
OurBrainBank publishes first feedback from patients